With the rising prevalence of diabetes around the world, diabetic nephropathy is one of the most common types of chronic kidney disease. Early signs of a diabetic kidney disease can alert that the kidneys are in danger and diabetic nephropathy is in progress. Globally, due to the rise of obesity and diabetes in different regions of the world, the diabetic nephropathy market is witnessing significant growth. Diabetic neuropathy influences 50% of diabetic patients with common symptoms and associated neurological disorder.
Diabetic Nephropathy Market: Analyzing the Trends and Demands
Diabetic nephropathy is a kidney glomerulus disease that is mainly caused by high blood sugar. Speaking in terms of morbidity and mortality, diabetic nephropathy is one of the most significant complications for patients suffering with diabetes. Globally, around 60 to 70 percent of the diabetic population develops neuropathy. According to the World Health Organization (WHO) around 350 million people suffer from diabetes and nearly 80% of them belong to mediocre-income countries.
Currently, in the United States, there are nearly six million patients suffering from diabetic nephropathy and this population is expected to rise further in the next five years.
With a considerable number of diabetic cases going undiagnosed in the initial years of progression, patients are progressing into end stage renal failure (requiring dialysis) or death. Many regions in the world, including the U.S., have inadequate treatment facilities to cure this disease. Symptoms and signs of diabetic nephropathy in an extremely early stage of the disease are unknown. Hence, increasing usage of combination therapy is the recent market trend that has been gaining popularity in the global diabetic nephropathy market.
In addition, increasing research and development investments and activities in drug discovery and development are also observed to instill high growth in this market. Growing prevalence of obesity and diabetes and rising awareness of kidney-related disorders are some of the key drivers of the diabetic nephropathy market.
Persistence Market Research analysts forecast that the global diabetic nephropathy market will grow at a CAGR of 5.6% from 2014 to 2020 in order to reach US$3,145.9 million by 2020. The market was valued at US$2,262.2 million in 2014.
North America is the Leading Region in this Market
Diabetic nephropathy is a growing concern in many countries, especially in the developing economies that account for the maximum diabetes population in the world. Currently, North America and Europe are the two major markets for diabetic neuropathy industry, due to the presence of advanced medical services and equipment and concentration of market-leading companies such as Sanofi, Eli Lilly and Mitsubishi Tanabe Pharma.
Indeed, North America has the largest market share in the overall diabetic nephropathy market owing to medical advancements and drug developments. The global diabetic neuropathy market in North America is growing at a CAGR of 5.7% from 2014 to 2020 and is anticipated to reach US$1,302.0 million by the end of 2020. Earlier in 2014, the market was estimated at US$931.0 million.
Scope for Growth in Emerging Economies
The diabetic nephropathy market is also growing in terms of growth and drug development in Asia. Some of the fastest growing markets for diabetic nephropathy in Asia are China and Japan due to rising rates of several kidney-related diseases and increase in the diabetic population in these countries.
The disease modifying therapies (DMT) that use angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to treat diabetic nephropathy are considered to be the largest and fastest-growing mode of treatment in Asia. The global disease modifying therapies (DMT) market is growing at a CAGR of 5.8% from 2014 to 2020 and is expected to reach US$2,929.8 million in 2020.
Browse Full Diabetic Nephropathy Market Research Report With Complete TOC @ http://www.persistencemarketresearch.com/market-research/diabetic-nephropathy-market.asp